iSpecimen Inc. (ISPC)

USD 1.17

(-2.68%)

Long Term Debt Summary of iSpecimen Inc.

  • iSpecimen Inc.'s latest annual long term debt in 2023 was 29.13 Thousand USD , up 6.33% from previous year.
  • iSpecimen Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • iSpecimen Inc. reported annual long term debt of 27.39 Thousand USD in 2022, down -99.2% from previous year.
  • iSpecimen Inc. reported annual long term debt of 3.42 Million USD in 2021, up 1813.16% from previous year.
  • iSpecimen Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • iSpecimen Inc. reported quarterly long term debt of 29.13 Thousand USD for 2023 FY, up 6.33% from previous quarter.

Annual Long Term Debt Chart of iSpecimen Inc. (2023 - 2018)

Created with Highcharts 11.1.0YearsLong Term Debt20182018.520192019.520202020.520212021.520222022.520230 USD2500000 USD5000000 USD7500000 USD10000000 USD12500000 USD15000000 USD

Historical Annual Long Term Debt of iSpecimen Inc. (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 29.13 Thousand USD 6.33%
2022 27.39 Thousand USD -99.2%
2021 3.42 Million USD 1813.16%
2020 178.89 Thousand USD -98.4%
2019 11.17 Million USD 0.0%
2018 11.17 Million USD 0.0%

Peer Long Term Debt Comparison of iSpecimen Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 99.052%
Applied DNA Sciences, Inc. 739.16 Thousand USD 96.059%
Aspira Women's Health Inc. 1.43 Million USD 97.963%
Biodesix, Inc. 35.22 Million USD 99.917%
BioNexus Gene Lab Corp. 98.76 Thousand USD 70.505%
bioAffinity Technologies, Inc. 1.11 Million USD 97.396%
bioAffinity Technologies, Inc. 1.11 Million USD 97.396%
Bionano Genomics, Inc. 7.17 Million USD 99.594%
CareDx, Inc 28.27 Million USD 99.897%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD 99.795%
DarioHealth Corp. 24.59 Million USD 99.882%
Exact Sciences Corporation 2.47 Billion USD 99.999%
Fulgent Genetics, Inc. 10.11 Million USD 99.712%
Guardant Health, Inc. 1.13 Billion USD 99.997%
ICON Public Limited Company 3.66 Billion USD 99.999%
IDEXX Laboratories, Inc. 622.88 Million USD 99.995%
Illumina, Inc. 1.48 Billion USD 99.998%
Intelligent Bio Solutions Inc. 81.32 Thousand USD 64.18%
Standard BioTools Inc. 3.98 Million USD 99.269%
MDxHealth SA 35.56 Million USD 99.918%
23andMe Holding Co. 67.84 Million USD 99.957%
Medpace Holdings, Inc. 142.12 Million USD 99.98%
Myriad Genetics, Inc. 130.9 Million USD 99.978%
Mainz Biomed B.V. 2.19 Million USD 98.673%
ENDRA Life Sciences Inc. 192.06 Thousand USD 84.833%
NeoGenomics, Inc. 606.06 Million USD 99.995%
Neogen Corporation 888.39 Million USD 99.997%
Inotiv, Inc. 399.4 Million USD 99.993%
Natera, Inc. 282.94 Million USD 99.99%
OpGen, Inc. 2.02 Million USD 98.559%
OPKO Health, Inc. 222.03 Million USD 99.987%
Psychemedics Corporation 945 Thousand USD 96.917%
Prenetics Global Limited 867.21 Thousand USD 96.641%
Prenetics Global Limited 867.21 Thousand USD 96.641%
Precipio, Inc. 106 Thousand USD 72.519%
Personalis, Inc. 1.23 Million USD 97.639%
RadNet, Inc. 812.06 Million USD 99.996%
Sera Prognostics, Inc. 840 Thousand USD 96.532%
Sotera Health Company 2.22 Billion USD 99.999%
Neuronetics, Inc. 59.28 Million USD 99.951%
Star Equity Holdings, Inc. 1.14 Million USD 97.456%
Star Equity Holdings, Inc. 1.14 Million USD 97.456%
Trinity Biotech plc 54.65 Million USD 99.947%
T2 Biosystems, Inc. 6.59 Million USD 99.559%
Twist Bioscience Corporation 79.17 Million USD 99.963%
Exagen Inc. 19.23 Million USD 99.849%